LILRB4
(Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 4 (LILRB4))
Reaktivität
Maus
Wirt
Armenischer Hamster
Klonalität
Monoklonal
Konjugat
Dieser LILRB4 Antikörper ist konjugiert mit PE
Applikation
Flow Cytometry (FACS)
Aufreinigung
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
CD85K antikoerper, ILT-3 antikoerper, ILT3 antikoerper, LIR-5 antikoerper, LIR5 antikoerper, Gp49b antikoerper, HM18 antikoerper, gp49 antikoerper, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 antikoerper, leukocyte immunoglobulin like receptor B4 antikoerper, leukocyte immunoglobulin-like receptor, subfamily B, member 4A antikoerper, LILRB4 antikoerper, Lilrb4a antikoerper
Hintergrund
Gp49, also known as ILT3, gp49b1 or CD85k, is a 49 kD glycoprotein expressed on activated NK cells and myeloid cells. It structurally resembles killer inhibitory receptors (KIR). gp49B is a type I membrane protein belonging to the Ig superfamily and contains an immunoreceptor tyrosine-based inhibitory motif (ITIM), while gp49A is a truncated molecule without ITIM. Upon activation following interaction with integrin a vb3, the cytoplasmic tail associates with SHP-1 and SHP-2, which results in downregulation of cell activation and cytokine production.